ADAR1 Capital Management, LLC

Holdings History for Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Symbol: IKT on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Shares Owned: 12,692,387 shares
Security Ownership %: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

ADAR1 Capital Management GP, LLC ownership in Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT)

17 Feb 2026 - ADAR1 Capital Management GP, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,692,387 shares of Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT). This represents 9.9% ownership of the company. In their previous filing dated 14 Aug 2025, ADAR1 Capital Management, LLC had reported owning 7,737,694 shares, indicating an increase of +64%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ADAR1 Capital Management GP, LLC	9.9%	0%	$25,384,774	12,692,387	+4,954,693	+64%	$2.00	13G/A	31 Dec 2025	17 Feb 2026, 18:22
ADAR1 Capital Management GP, LLC	9.9%	-0.9%	$14,314,734	7,737,694	+743,448	+11%	$1.85	13G/A	30 Jun 2025	14 Aug 2025, 20:27
ADAR1 Capital Management GP, LLC	10%		$15,806,996	6,994,246			$2.26	13G	31 Dec 2024	14 Feb 2025, 21:04

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.2%	+0.43%	$16,531,095	8,063,949	+2,816,346	+54%	$2.05	Q4 2025
30 Sep 2025	0.85%	+0.02%	$8,501,117	5,247,603	+125,498	+2.5%	$1.62	Q3 2025
30 Jun 2025	1.6%	0%	$9,988,105	5,122,105	0		$1.95	Q2 2025
31 Mar 2025	2.2%	+0.01%	$11,217,410	5,122,105	+19,100		$2.19	Q1 2025
31 Dec 2024	3.4%	+3.4%	$16,584,766	5,103,005	+5,103,005	NEW	$3.25	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.